Lowe syndrome protein OCRL1 interacts with Rac GTPase in the trans-Golgi network

Human Molecular Genetics

Volumn 12, Issue 19, 2003, Pages 2449-2456

  Faucherre, Adèle ^a   Desbois, Pierrette ^a   Satre, Véronique ^b   Lunardi, Joël ^b   Dorseuil, Olivier ^a   Gacon, Gérard ^a  

^a INSTITUT COCHIN   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; GUANOSINE TRIPHOSPHATE; PHOSPHATASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PROTEIN CDC42; PROTEIN OCRL1; RHO FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE LOSS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; IN VITRO STUDY; LOWE SYNDROME; MENTAL DEFICIENCY; MOLECULAR STABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANS GOLGI NETWORK;

ADAPTOR PROTEIN COMPLEX GAMMA SUBUNITS; ANIMALS; BREFELDIN A; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME ACTIVATION; HELA CELLS; HUMANS; MICE; OCULOCEREBRORENAL SYNDROME; PHOSPHORIC MONOESTER HYDROLASES; PRECIPITIN TESTS; PROTEIN STRUCTURE, TERTIARY; PROTEIN SYNTHESIS INHIBITORS; PROTEINS; RHO GTP-BINDING PROTEINS; SWISS 3T3 CELLS; TRANS-GOLGI NETWORK; X CHROMOSOME;

ANIMALIA;

EID: 0141618321     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg250     Document Type: Article

References (44)

1. Takai, Y., Sasaki, T. and Matozaki, T. (2001) Small GTP-binding proteins. Physiol. Rev., 81, 153-208.
2. Van Aelst, L. and D'Souza-Schorey, C. (1997) Rho GTPases and signaling networks. Genes Dev., 11, 2295-2322.
3. Etienne-Manneville, S. and Hall, A. (2002) Rho GTPases in cell biology. Nature, 420, 629-635.
4. Luo, L. (2000) Rho GTPases in neuronal morphogenesis. Nat. Rev. Neurosci., 1, 173-180.
5. Bonhoeffer, T. and Yuste, R. (2002) Spine motility. Phenomenology, mechanisms, and function. Neuron, 35, 1019-1027.
6. Jaffe, A.B. and Hall, A. (2002) Rho GTPases in transformation and metastasis. Adv. Cancer Res., 84, 57-80.
7. Sahai, E. and Marshall, C.J. (2002) RHO-GTPases and cancer. Nature Rev. Cancer, 2, 133-142.
8. Chelly, J. and Mandel, J.L. (2001) Monogenic causes of X-linked mental retardation. Nat. Rev. Genet., 2, 669-680.
9. Ramakers, G.J. (2002) Rho proteins, mental retardation and the cellular basis of cognition. Trends Neurosci., 25, 191-199.
10. Billuart, P., Bienvenu, T., Ronce, N., des Portes, V., Vinet, M.C., Zemni, R., Crollius, H.R., Carrie, A., Fauchereau, F., Cherry, M. et al. (1998) Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature, 392, 923-926.
11. Kutsche, K., Yntema, H., Brandt, A., Jantke, I., Nothwang, H.G., Orth, U., Boavida, M.G., David, D., Chelly, J., Fryns, J.P. et al. (2000) Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation. Nat. Genet., 26, 247-250.
12. Allen, K.M., Gleeson, J.G., Bagrodia, S., Partington, M.W., MacMillan, J.C., Cerione, R.A., Mulley, J.C. and Walsh, C.A. (1998) PAK3 mutation in nonsyndromic X-linked mental retardation. Nat. Genet., 20, 25-30.
13. Endris, V., Wogatzky, B., Leimer, U., Bartsch, D., Zatyka, M., Latif, F., Maher, E.R., Tariverdian, G., Kirsch, S., Karch, D. et al. (2002) The novel Rho-GTPase activating gene MEGAP/srGAP3 has a putative role in severe mental retardation. Proc. Natl Acad. Sci. USA, 99, 11754-11759.
14. Pasteris, N.G., Cadle, A., Logie, L.J., Porteous, M.E., Schwartz, C.E., Stevenson, R.E., Glover, T.W., Wilroy, R.S. and Gorski, J.L. (1994) Isolation and characterization of the faciogenital dysplasia (Aarskog-Scott syndrome) gene: a putative Rho/Rac guanine nucleotide exchange factor. Cell, 79, 669-678.
15. Lamb, R.F., Roy, C., Diefenbach, T.J., Vinters, H.V., Johnson, M.W., Jay, D.G. and Hall, A. (2000) The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat. Cell Biol., 2, 281-287.
16. Astrinidis, A., Cash, T.P., Hunter, D.S., Walker, C.L., Chernoff, J. and Henske, E.P. (2002) Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration. Oncogene, 21, 8470-8476.
17. Frangiskakis, J.M., Ewart, A.K., Morris, C.A., Mervis, C.B., Bertrand, J., Robinson, B.F., Klein, B.P., Ensing, G.J., Everett, L.A., Green, E.D. et al. (1996) LIM-kinase1 hemizygosity implicated in impaired visuospatial constructive cognition. Cell, 86, 59-69.
18. Attree, O., Olivos, I.M., Okabe, I., Bailey, L.C., Nelson, D.L., Lewis, R.A., McInnes, R.R. and Nussbaum, R.L. (1992) The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature, 358, 239-242.
19. Peck, J., Douglas, G.T., Wu, C.H. and Burbelo, P.D. (2002) Human RhoGAP domain-containing proteins: structure, function and evolutionary relationships. FEBS Lett., 528, 27-34.
20. Zhang, X., Jefferson, A.B., Auethavekiat, V. and Majerus, P.W. (1995) The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase. Proc. Natl Acad. Sci. USA, 92, 4853-4856.
21. Suchy, S.F., Olivos-Glander, I.M. and Nussabaum, R.L. (1995) Lowe syndrome, a deficiency of phosphatidylinositol 4,5-bisphosphate 5-phosphatase in the Golgi apparatus. Hum. Mol. Genet., 4, 2245-2250.
22. Dressman, M.A., Olivos-Glander, I.M., Nussbaum, R.L. and Suchy, S.F. (2000) Ocrl1, a PtdIns(4,5)P(2) 5-phosphatase, is localized to the trans-Golgi network of fibroblasts and epithelial cells. J. Histochem. Cytochem., 48, 179-190.
23. Ungewickell, A.J. and Majerus, P.W. (1999) Increased levels of plasma lysosomal enzymes in patients with Lowe syndrome. Proc. Natl Acad. Sci. USA, 96, 13342-13344.
24. Zhang, X., Hartz, P.A., Philip, E., Racusen, L.C. and Majerus, P.W. (1998) Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate. J. Biol. Chem., 273, 1574-1582.
25. Lin, T., Orrison, B.M., Leahey, A.M., Suchy, S.F., Bernard, D.J., Lewis, R.A. and Nussbaum, R.L. (1997) Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome. Am. J. Hum. Genet., 60, 1384-1388.
26. Lin, T., Orrison, B.M., Suchy, S.F., Lewis, R.A. and Nussbaum, R.L. (1998) Mutations are not uniformly distributed throughout the OCRL1 gene in Lowe syndrome patients. Mol. Genet. Metab., 64, 58-61.
27. Satre, V., Monnier, N., Berthoin, F., Ayuso, C., Joannard, A., Jouk, P.S., Lopez-Pajares, I., Megabarne, A., Philippe, H.J., Plauchu, H. et al. (1999) Characterization of a germline mosaicism in families with Lowe syndrome, and identification of seven novel mutations in the OCRL1 gene. Am. J. Hum. Genet., 65, 68-76.
28. Loovers, H.M., Veenstra, K., Snippe, H., Pesesse, X., Erneux, C. and Van Haastert, P.J. (2002) A diverse family of inositol 5-phosphatases playing a role in growth and development in dictyostelium discoideum. J. Biol. Chem., 2, 2.
29. Janne, P.A., Suchy, S.F., Bernard, D., MacDonald, M., Crawley, J., Grinberg, A., Wynshaw-Boris, A., Westphal, H. and Nussbaum, R.L. (1998) Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice. J. Clin. Invest., 101, 2042-2053.
30. Feig, L.A. (1999) Tools of the trade: use of dominant-inhibitory mutants of Ras-family GTPases. Nat. Cell Biol., 1, E25-27.
31. Toure, A., Dorseuil, O., Morin, L., Timmons, P., Jegou, B., Reibel, L. and Gacon, G. (1998) MgcRacGAP, a new human GTPase-activating protein for Rac and Cdc42 similar to Drosophila rotundRacGAP gene product, is expressed in male germ cells. J. Biol. Chem., 273, 6019-6023.
32. Olivos-Glander, I.M., Janne, P.A. and Nussbaum, R.L. (1995) The oculocerebrorenal syndrome gene product is a 105-kD protein localized to the Golgi complex. Am. J. Hum. Genet., 57, 817-823.
33. Stearns, T., Evans, L. and Kirschner, M. (1991) Gamma-tubulin is a highly conserved component of the centrosome. Cell, 65, 825-836.
34. Erickson, J.W., Zhang, C., Kahn, R.A., Evans, T. and Cerione, R.A. (1996) Mammalian Cdc42 is a brefeldin A-sensitive component of the Golgi apparatus. J. Biol. Chem., 271, 26850-26854.
35. Musch, A., Cohen, D., Kreitzer, G. and Rodriguez-Boulan, E. (2001) cdc42 regulates the exit of apical and basolateral proteins from the trans-Golgi network. EMBO J., 20, 2171-2179.
36. Hall, A. (1998) Rho GTPases and the actin cytoskeleton. Science, 279, 509-514.
37. Ridley, A.J. (2001) Rho family proteins: coordinating cell responses. Trends Cell Biol., 11, 471-477.
38. Kraynov, V.S., Chamberlain, C., Bokoch, G.M., Schwartz, M.A., Slabaugh, S. and Hahn, K.M. (2000) Localized Rac activation dynamics visualized in living cells. Science, 290, 333-337.
39. Doye, A., Mettouchi, A., Bossis, G., Clement, R., Buisson-Touati, C., Flatau, G., Gagnoux, L., Piechaczyk, M., Boquet, P., and Lemichez, E. (2002) CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion. Cell, 111, 553-564.
40. Seewald, M.J., Korner, C., Wittinghofer, A. and Vetter, I.R. (2002) RanGAP mediates GTP hydrolysis without an arginine finger. Nature, 415, 662-666.
41. Brinkmann, T., Daumke, O., Herbrand, U., Kuhlmann, D., Stege, P., Ahmadian, M.R. and Wittinghofer, A. (2002) Rap-specific GTPase activating protein follows an alternative mechanism. J. Biol. Chem., 277, 12525-12531.
42. Van Aelst, L. and Symons, M. (2002) Role of Rho family GTPases in epithelial morphogenesis. Genes Dev., 16, 1032-1054.
43. Sander, E.E., ten Klooster, J.P., van Delft, S., van der Kammen, R.A. and Collard, J.G. (1999) Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J. Cell Biol., 147, 1009-1022.
44. Zondag, G.C., Evers, E.E., ten Klooster, J.P., Janssen, L., van der Kammen, R.A., and Collard, J.G. (2000) Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition. J. Cell Biol., 149, 775-782.